Airways Eosinophils as Antigen-presenting Cells in Asthma
Airways Eosinophils as Antigen-presenting Cells in Asthma
批准号:
7921759
负责人:
PETER F WELLER
金额:
$29.12万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-17 至 2011-09-16
关键词:
AbbreviationsAllergensAllergicAntibodiesAntigen PresentationAntigen-Presenting CellsAntigensAsthmaB-LymphocytesBronchoalveolar LavageCell CommunicationCell physiologyCellsCessation of lifeChronicCytoplasmic GranulesDendritic CellsDiseaseEicosanoidsElectron MicroscopyEotaxinErythrocytesFc ReceptorHen Egg LysozymeHumanIgEIgG ReceptorsImmuneImmunizationImmunoglobulin AImmunoglobulin GInflammationInflammation MediatorsKnock-outLeukocytesLeukotriene C4LigandsLungLymphocyteLymphocyte antigen CD50LymphoidLymphoid CellLymphoid TissueMHC Class II GenesMediatingMediationMusMyelogenousNatureOrganOvalbuminParatrachealParticipantProcessProteinsPublic HealthReceptors, Antigen, B-CellRecruitment ActivityRegulationResearchRespiratory SystemRespiratory tract structureRoleSLAM proteinSiteSpleenSputumStagingStructure of thyroid parafollicular cellSynapsesT-Cell ReceptorT-LymphocyteTSLP geneTestingThymus GlandTransgenic OrganismsTransport Processallergic airway diseasealuminum sulfatebasecysteinyl-leukotrienecytokineeosinophileosinophil peroxidasegastrointestinalhuman TSLP proteinin vivoinsightintraperitoneallymph nodesnovelparacrineprogramspublic health relevancereceptorresponsetrafficking
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Studies will investigate capabilities and mechanisms whereby eosinophils, including those recruited within airways in asthma, function as antigen-presenting cells that are of importance in propagating or modulating varied lymphocyte-dependent responses to respiratory tract encountered antigens. As antigen-presenting cells, eosinophils have distinct capabilities: First, airway eosinophils express requisite Class II MHC and lymphocyte costimulatory proteins. Second, eosinophils, like dendritic cells, function as "professional" antigen-presenting cells in expressing lymphocyte costimulatory proteins and activating unsensitized, naive T cells. Third, eosinophils, in contrast to other antigen-presenting cells, contain preformed stores of diverse cytokines that can be rapidly and selectively secreted to modulate varied lymphocyte responses. Fourth, eosinophils, like other antigen-presenting cells, utilize Fc receptor- mediated mechanisms to enhance antigen presentation by antigen-presenting cells. Eosinophil IgE, IgA and IgG receptors, together with airway allergen-specific IgE, IgA and IgG antibodies, can effectively present allergens. Fifth, airway eosinophils traffick into lymph nodes, spleen and even the thymus enabling airway antigens to be processed and transported into regional and systemic lymphoid tissues for presentation to varied lymphocytes. Sixth, eosinophils express ligands and receptors classically associated with dendritic cells, including DC-SIGN. Moreover, eosinophils can modulate B lymphocyte responses since eosinophils are critical participants in alum immunization-mediated B cell priming. Hypotheses to be tested are: that eosinophils trafficking from the airways are effective at presenting antigens to regulate, potentially differing, T lymphocyte responses in both regional and systemic lymphoid cells; that selective, restricted secretion of eosinophil cytokines mediates differential regulation of eosinophil antigen-presenting cell functions; and that eosinophils have roles in mediating the priming and responsiveness of B cells. Studies aim to investigate mechanisms by which eosinophils traffic and function as antigen-presenting cells to regulate regional and systemic T cell responses; eosinophil cytokines function in differential mediation of eosinophil antigen-presenting cell functions, and eosinophils function in B cell priming and activation. Roles for eosinophils as antigen-presenting cells in mediating allergic responses to airway antigens would provide novel insights into the characteristically chronic nature of asthma and other allergic airway diseases. PUBLIC HEALTH RELEVANCE. Asthma is an increasingly prevalent disease and a major public health problem. The research will help in understanding mechanisms that contribute to making asthma a chronic and persistent disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Human Eosinophils: Mechanisms of Functioning
-
批准号:9242550
-
项目类别:
-
资助金额:$53.36万
-
财政年份:2015
-
负责人:PETER F WELLER
-
依托单位:
Human Eosinophils: Mechanisms of Functioning
-
批准号:7878373
-
项目类别:
-
资助金额:$1.97万
-
财政年份:2009
-
负责人:PETER F WELLER
-
依托单位:
Multi-Laser Flow Cytometer
-
批准号:6730722
-
项目类别:
-
资助金额:$27.3万
-
财政年份:2004
-
负责人:PETER F WELLER
-
依托单位:
MULTI-LASER FLOW CYTOMETER: CANCER: BREAST, PROSTATE
-
批准号:6973415
-
项目类别:
-
资助金额:$8.19万
-
财政年份:2004
-
负责人:PETER F WELLER
-
依托单位:
MULTI-LASER FLOW CYTOMETER: INFECTIOUS DIS, HERPE VIRUS, HCV
-
批准号:6973417
-
项目类别:
-
资助金额:$8.19万
-
财政年份:2004
-
负责人:PETER F WELLER
-
依托单位:
MULTI-LASER FLOW CYTOMETER: HIV
-
批准号:6973414
-
项目类别:
-
资助金额:$2.73万
-
财政年份:2004
-
负责人:PETER F WELLER
-
依托单位:
MULTI-LASER FLOW CYTOMETER: LUNG, AIRWAY & ALLERGIC INFLAMMATION
-
批准号:6973416
-
项目类别:
-
资助金额:$8.19万
-
财政年份:2004
-
负责人:PETER F WELLER
-
依托单位:
Eosinophils in Pulmonary Fibrosis
-
批准号:6850807
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2002
-
负责人:PETER F WELLER
-
依托单位:
Eosinophils in Pulmonary Fibrosis
-
批准号:6731179
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2002
-
负责人:PETER F WELLER
-
依托单位:
Eosinophil Lipid Bodies in Allergic Inflammation
-
批准号:6480631
-
项目类别:
-
资助金额:$3.85万
-
财政年份:2002
-
负责人:PETER F WELLER
-
依托单位:
Eosinophil Lipid Bodies in Allergic Inflammation
-
批准号:6625959
-
项目类别:
-
资助金额:$3.87万
-
财政年份:2002
-
负责人:PETER F WELLER
-
依托单位:
Eosinophils in Pulmonary Fibrosis
-
批准号:6465037
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2002
-
负责人:PETER F WELLER
-
依托单位:
CXC chemokines in pathogenesis of pulmonary fibrosis
-
批准号:6616348
-
项目类别:
-
资助金额:$18.24万
-
财政年份:2002
-
负责人:PETER F WELLER
-
依托单位:
Eosinophils in Pulmonary Fibrosis
-
批准号:6623359
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2002
-
负责人:PETER F WELLER
-
依托单位:
Eosinophil Lipid Bodies in Allergic Inflammation
-
批准号:6739694
-
项目类别:
-
资助金额:$3.97万
-
财政年份:2002
-
负责人:PETER F WELLER
-
依托单位:
EOSINOPHILS IN PULMONARY FIBROTIC DISEASE
-
批准号:6411236
-
项目类别:
-
资助金额:$30.86万
-
财政年份:2001
-
负责人:PETER F WELLER
-
依托单位:
Airways eosinophils as antigen-presenting cells-asthma
-
批准号:6762385
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2001
-
负责人:PETER F WELLER
-
依托单位:
Airways Eosinophils as Antigen-presenting Cells in Asthma
-
批准号:7591646
-
项目类别:
-
资助金额:$42.5万
-
财政年份:2001
-
负责人:PETER F WELLER
-
依托单位:
Airways eosinophils as antigen-presenting cells-asthma
-
批准号:6511833
-
项目类别:
-
资助金额:$36.34万
-
财政年份:2001
-
负责人:PETER F WELLER
-
依托单位:
Airways Eosinophils as Antigen-presenting Cells in Asthma
-
批准号:8071570
-
项目类别:
-
资助金额:$41.65万
-
财政年份:2001
-
负责人:PETER F WELLER
-
依托单位:
海外基金